In one paragraphArticle in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 41% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 7 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
14 authors at 4 institutions in 2 countries.
Malgorzata Tyszka-CzocharaFaculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Krakow, Poland.
Marzena SuderDepartment of Crystal Chemistry and Crystal Physics, Faculty of Chemistry, Jagiellonian University, Gronostajowa 2, 30-387 Krakow, Poland.
Agnieszka Dołhańczuk-ŚródkaInstitute of Environmental Engineering and Biotechnology, University of Opole, Kominka 6, 45-035 Opole, Poland.ORCID 0000-0002-9654-4111 Małgorzata RajfurInstitute of Environmental Engineering and Biotechnology, University of Opole, Kominka 6, 45-035 Opole, Poland.ORCID 0000-0002-4544-9819 Katarzyna GrataInstitute of Environmental Engineering and Biotechnology, University of Opole, Kominka 6, 45-035 Opole, Poland.
Michał StarostaInstitute of Environmental Engineering and Biotechnology, University of Opole, Kominka 6, 45-035 Opole, Poland.
Agnieszka Jagoda-PasternakDepartment of General and Inorganic Chemistry, Faculty of Chemical Engineering and Technology, Cracow University of Technology, Warszawska 24, 31-155 Krakow, Poland.ORCID 0000-0003-1434-5280 Wiktor KasprzykDepartment of Biotechnology and Physical Chemistry, Faculty of Chemical Engineering and Technology, Cracow University of Technology, Warszawska 24, 31-155 Krakow, Poland.ORCID 0000-0001-6475-7991 Anna K NowakDepartment of General and Inorganic Chemistry, Faculty of Chemical Engineering and Technology, Cracow University of Technology, Warszawska 24, 31-155 Krakow, Poland.
Saeid AhmadzadehPharmaceutics Research Centre, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman 7616913555, Iran.ORCID 0000-0001-8574-9448 Dorota KopećDepartment of Chemical Technology and Environmental Analysis, Faculty of Chemical Engineering and Technology, Cracow University of Technology, Warszawska 24, 31-155 Krakow, Poland.
Piotr SuryłoDepartment of Chemical Technology and Environmental Analysis, Faculty of Chemical Engineering and Technology, Cracow University of Technology, Warszawska 24, 31-155 Krakow, Poland.
Tomasz ŚwiergoszDepartment of Chemical Technology and Environmental Analysis, Faculty of Chemical Engineering and Technology, Cracow University of Technology, Warszawska 24, 31-155 Krakow, Poland.ORCID 0000-0002-5317-1597 Katarzyna M StadnickaDepartment of Crystal Chemistry and Crystal Physics, Faculty of Chemistry, Jagiellonian University, Gronostajowa 2, 30-387 Krakow, Poland.ORCID 0000-0002-3898-5824 Cracow University of Technology · PLUniversity of Opole · PLJagiellonian University · PLKerman University of Medical Sciences · IR
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Innovative engineering design for biologically active hydroxyapatites requires enhancing both mechanical and physical properties, along with biocompatibility, by doping with appropriate chemical elements. Herein, the purpose of this investigation was to evaluate and elucidate the model of naturally occurring hydroxyapatite and the effects of doped trace elements on the function of normal human fibroblasts, representing the main cells of connective tissues. The substrates applied (geological apatites with hexagonal prismatic crystal habit originated from Slyudyanka, Lake Baikal, Russia (GAp) and from Imilchil, The Atlas Mountains, Morocco (YAp)) were prepared from mineral natural apatite with a chemical composition consistent with the building blocks of enamel and enriched with a significant F
Indexed as
FibroblastsApatitesBiocompatible MaterialsCell ProliferationCell SurvivalChemical PhenomenaDurapatiteHumansMineralsSpectrum AnalysisTrace ElementsApatitesBiocompatible MaterialsDurapatiteMineralsTrace Elementscell–surface interactionsfibroblast cell cultureFTIRhydroxyapatitemineral apatite single crystalsSEM-EDXSX-ray diffraction
Identifiers
PMID35054988
PMCPMC8775611
OpenAlexW4206182467
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390